Background: The surface epithelial glycoprotein MUC adenocarcinomas; similar changes occur during nonmali against tumor-like MUC1 in response to such events cou factors operate. nti-M alth S cted.03), t antibo s rem ls we Introdu The hu glycosyl normal e form is cluding b MUC1 a time of healthy nant or ural im-t for the astfeed-ther fac-ng oral during ntibody t immu-least in n repro-risk (9). design. Thus, we measured anti-MUC1 antibodies in ian cancer, in which cases provided blood samples at uate the relation-tibodies and ris
We investigated whether epithelial ovarian cancer patients participating in a randomized phase III t...
Introduction: Detection of serum biomarkers for early diagnosis of breast cancer remains an importan...
Introduction: Detection of serum biomarkers for early diagnosis of breast cancer remains an importan...
Many cancers, including ovarian, overexpress epithelial mucin (MUC1) and promote anti-MUC1 antibodie...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Contains fulltext : 69735.pdf (publisher's version ) (Closed access)We investigate...
BACKGROUND: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3 and CA125, and g...
BACKGROUND: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3 and CA125, and g...
Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and ...
Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and ...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and ...
We investigated whether epithelial ovarian cancer patients participating in a randomized phase III t...
Introduction: Detection of serum biomarkers for early diagnosis of breast cancer remains an importan...
Introduction: Detection of serum biomarkers for early diagnosis of breast cancer remains an importan...
Many cancers, including ovarian, overexpress epithelial mucin (MUC1) and promote anti-MUC1 antibodie...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Contains fulltext : 69735.pdf (publisher's version ) (Closed access)We investigate...
BACKGROUND: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3 and CA125, and g...
BACKGROUND: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3 and CA125, and g...
Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and ...
Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and ...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Aims: Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberran...
Background: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3, and CA125, and ...
We investigated whether epithelial ovarian cancer patients participating in a randomized phase III t...
Introduction: Detection of serum biomarkers for early diagnosis of breast cancer remains an importan...
Introduction: Detection of serum biomarkers for early diagnosis of breast cancer remains an importan...